Publication | Open Access

Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant

Car T CellsCell TherapyTransplantationLow ToxicityMedicineStem Cell TransplantationImmunologyHematologyAutoimmunityGraft SurvivalRadiation OncologyImmunotherapyCell TransplantationRelapsed/refractory B-allHealth Sciences